skip to Main Content

National Institute of Health’s (NIH) assessment of Cannabinoids on Various Ailments

BERKELEY, CA - MARCH 25:  One-ounce bags of medicinal marijuana are displayed at the Berkeley Patients Group March 25, 2010 in Berkeley, California.  California Secretary of State Debra Bowen certified a ballot initiative late Wednesday to legalize the possession and sale of marijuana in the State of California after proponents of the measure submitted over 690,000 signatures. The measure will appear on the November 2 general election ballot.  (Photo by Justin Sullivan/Getty Images)

Photo by Justin Sullivan/Getty Images

For those of you who read the article about me in the Valley Advocate here is a sampling of bona fide scientific studies on the U.S. Federal Government’s National Institute of Health website. I recommend doing a search for “scholarly article Cannabinoids NIH or National Academy of Science.” Remember that many departments and people in the science, health, and government fields are familiar with the uninformed, cultural perceptions of marijuana, and some members of those fields are informed. It’s a rift and it is interesting but all health practitioners should examine both the spectrum of evidence detailing harm and benefits of marijuana AS WELL AS the spectrum of evidence detailing the harm and benefits of readily available prescription pharmaceuticals.

I am always available to speak to individuals and groups in order to parse out objective evidence and inform the community.

Scientific studies largely confirm the benefit of exogenous cannabinoids on neuropathic pain.

Cannabis use in Palliative care; evidence largely supports the benefits.

An analyses of the evidence for managing chronic pain with cannabis.

Leave a Reply

Your email address will not be published.

Back To Top